Identification of a Safe and Non-Psychedelic Dose of Psilocybin
Clinical trial NCT07710027 · COMPLETED
Trial details
- NCT number
- NCT07710027
- Sponsor
- Diamond Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2022-03-12
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.